Ashutosh Chilkoti
Ashutosh Chilkoti publishes mostly in Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, on topics such as RNA Research and Splicing, Advanced Biosensing Techniques and Applications and RNA and protein synthesis mechanisms.
- World rank
- #1,607,330 of 7,710,434 ranked researchers
- Rank in United States
- #499,939 of 1,627,098
- Works
- 21
- Citations
- 1k
- Citations per work
- 48.2
What does Ashutosh Chilkoti research?
Ashutosh Chilkoti's work is mostly in Biochemistry, Genetics and Molecular Biology (48%), Engineering (12%), Medicine (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1048.3%
- Everything else628.4%
- Physical Sciences418.3%
- Engineering211.7%
- Materials Science13.3%
- Physics and Astronomy13.3%
- Health Sciences15.0%
- Medicine15.0%
- 1Molecular Biology45% of their works
- 2Biomedical Engineering12% of their works
- 3Radiology, Nuclear Medicine and Imaging5% of their works
- 4Cell Biology3% of their works
- 5Atomic and Molecular Physics, and Optics3% of their works
- 6Surfaces, Coatings and Films3% of their works
Research topics
- RNA Research and Splicing
- Advanced Biosensing Techniques and Applications
- RNA and protein synthesis mechanisms
- Monoclonal and Polyclonal Antibodies Research
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- Microfluidic and Bio-sensing Technologies
- Biosensors and Analytical Detection
Which keywords describe Ashutosh Chilkoti's research?
The keywords of their largest research topics: Alternative Splicing, RNA-Binding Proteins, Biosensors, High-Throughput Analysis, Lab-on-a-Chip, Protein Microarrays, Fc Receptors and Ribosome.
- m6A-seq
- RNA methylation
- Paper-Based Microfluidics
- Loop-Mediated Isothermal Amplification
- Translation
- Ribosome
- Protein Microarrays
- High-Throughput Analysis
- RNA-Binding Proteins
- Alternative Splicing
- Biosensors
- Lab-on-a-Chip
- Fc Receptors
- Therapeutic Antibodies
- DNA nanotechnology
- Microfluidics
- Particle Separation
- Self-Assembly
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Alternative Splicing71 topic
- RNA-Binding Proteins71 topic
- Biosensors42 topics
- High-Throughput Analysis41 topic
- Lab-on-a-Chip42 topics
- Protein Microarrays41 topic
- Fc Receptors31 topic
- Ribosome31 topic
- Therapeutic Antibodies31 topic
- Translation31 topic
- DNA nanotechnology21 topic
- Loop-Mediated Isothermal Amplification21 topic
- Microfluidics21 topic
- Paper-Based Microfluidics21 topic
- Particle Separation21 topic
- RNA methylation21 topic
- Self-Assembly21 topic
- m6A-seq21 topic
Where does Ashutosh Chilkoti work?
Ashutosh Chilkoti's main affiliation in the publication record is Duke University, United States.
How many publications and citations does Ashutosh Chilkoti have?
OpenAlex counts 21 works and 1,013 citations for Ashutosh Chilkoti, an h-index of 13, ranking #1,607,330 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Ashutosh Chilkoti
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ashutosh Chilkoti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.